In previous study, the genes (CDK1, CDK2 and CDK4) were dysregulated in breast cancer [42], ovarian cancer [43], colon cancer [44], hepatocellular carcinoma [45], thyroid carcinoma [46], and lung cancer [47]. Here, CDK2 is linked to thyroid gland carcinoma.